Related Experiment Video
Updated: Aug 5, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
Research Advances on the Stability of mRNA Vaccines
Feiran Cheng1,2, Yiping Wang3, Yu Bai1,2
1National Medical Products Administration Key Laboratory for Quality Research and Evaluation of Biological Products, Institute of Biological Products, National Institutes for Food and Drug Control, Beijing 102600, China.
Abstract:
Compared to other vaccines, the inherent properties of messenger RNA (mRNA) vaccines and their interaction with lipid nanoparticles make them considerably unstable throughout their life cycles, impacting their effectiveness and global accessibility. It is imperative to improve mRNA vaccine stability and investigate the factors influencing stability. Since mRNA structure, excipients, lipid nanoparticle (LNP) delivery systems, and manufacturing processes are the primary factors affecting mRNA vaccine stability, optimizing mRNA structure and screening excipients can effectively improve mRNA vaccine stability. Moreover, improving manufacturing processes could also prepare thermally stable mRNA vaccines with safety and efficacy. Here, we review the regulatory guidance associated with mRNA vaccine stability, summarize key factors affecting mRNA vaccine stability, and propose a possible research path to improve mRNA vaccine stability.
Insights
Messenger RNA (mRNA) vaccines are unstable, limiting their effectiveness and accessibility. Optimizing mRNA structure, excipients, and manufacturing processes is crucial for developing more stable and globally accessible mRNA vaccines.
Area of Science:
- Vaccinology
- Biopharmaceutical Development
- Drug Delivery Systems
Background:
- Messenger RNA (mRNA) vaccines exhibit inherent instability due to their properties and lipid nanoparticle (LNP) interactions.
- This instability poses challenges to vaccine effectiveness, shelf-life, and global accessibility.
Purpose of the Study:
- To review regulatory guidance on mRNA vaccine stability.
- To summarize key factors influencing mRNA vaccine stability.
- To propose research avenues for enhancing mRNA vaccine stability.
Main Methods:
- Literature review of factors affecting mRNA vaccine stability.
- Analysis of regulatory guidelines pertinent to vaccine stability.
- Synthesis of current research and identification of future research directions.
Main Results:
- mRNA structure, excipients, LNP delivery systems, and manufacturing processes are identified as primary determinants of mRNA vaccine stability.
- Optimization of these factors presents a viable strategy for improving vaccine stability.
Conclusions:
- Improving mRNA vaccine stability is essential for enhancing vaccine effectiveness and global accessibility.
- Further research into optimizing mRNA structure, excipient screening, and manufacturing processes is recommended.
- Development of thermally stable mRNA vaccines is achievable through targeted interventions.
Related Concept Videos
RNA Stability
mRNA Stability and Gene Expression
Nuclear Export of mRNA
Microorganisms in Medicine and Therapeutics
Leaky Scanning
Improving Translational Accuracy

